Next Generation Cancer Diagnostics

The “Global Next Generation Cancer Diagnostics Market” is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Next Generation Cancer Diagnostics Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Global Next Generation Cancer Diagnostics Market discusses the opportunity areas for investors.

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Download Sample Copy Of This Report From Here: http://www.amecoresearch.com/sample/5805

The key players covered in this study
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation

Market segment by Type, the product can be split into
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Other

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

View Detail Report With Complete Table of Content@http://www.amecoresearch.com/market/global-next-generation-cancer-diagnostics-market-arc-5805

The study objectives of this report are:
To analyze global Next Generation Cancer Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Next Generation Cancer Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Next Generation Cancer Diagnostics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Global Next Generation Cancer Diagnostics Market Report 2018-2025
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type (2013-2025)
1.4.2 Next Generation Sequencing
1.4.3 qPCR & Multiplexing
1.4.4 DNA Microarrays
1.4.5 Other
1.5 Market by Application
1.5.1 Global Next Generation Cancer Diagnostics Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Next Generation Cancer Diagnostics Market Size
2.2 Next Generation Cancer Diagnostics Growth Trends by Regions
2.2.1 Next Generation Cancer Diagnostics Market Size by Regions (2013-2025)
2.2.2 Next Generation Cancer Diagnostics Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Next Generation Cancer Diagnostics Market Size by Manufacturers
3.1.1 Global Next Generation Cancer Diagnostics Revenue by Manufacturers (2013-2018)
3.1.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Next Generation Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Next Generation Cancer Diagnostics Key Players Head office and Area Served
3.3 Key Players Next Generation Cancer Diagnostics Product/Solution/Service
3.4 Date of Enter into Next Generation Cancer Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Next Generation Cancer Diagnostics Market Size by Type (2013-2018)
4.2 Global Next Generation Cancer Diagnostics Market Size by Application (2013-2018)

5 United States
5.1 United States Next Generation Cancer Diagnostics Market Size (2013-2018)
5.2 Next Generation Cancer Diagnostics Key Players in United States
5.3 United States Next Generation Cancer Diagnostics Market Size by Type
5.4 United States Next Generation Cancer Diagnostics Market Size by Application

6 Europe
6.1 Europe Next Generation Cancer Diagnostics Market Size (2013-2018)
6.2 Next Generation Cancer Diagnostics Key Players in Europe
6.3 Europe Next Generation Cancer Diagnostics Market Size by Type
6.4 Europe Next Generation Cancer Diagnostics Market Size by Application

7 China
7.1 China Next Generation Cancer Diagnostics Market Size (2013-2018)
7.2 Next Generation Cancer Diagnostics Key Players in China
7.3 China Next Generation Cancer Diagnostics Market Size by Type
7.4 China Next Generation Cancer Diagnostics Market Size by Application

8 Japan
8.1 Japan Next Generation Cancer Diagnostics Market Size (2013-2018)
8.2 Next Generation Cancer Diagnostics Key Players in Japan
8.3 Japan Next Generation Cancer Diagnostics Market Size by Type
8.4 Japan Next Generation Cancer Diagnostics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Next Generation Cancer Diagnostics Market Size (2013-2018)
9.2 Next Generation Cancer Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Next Generation Cancer Diagnostics Market Size by Type
9.4 Southeast Asia Next Generation Cancer Diagnostics Market Size by Application

10 India
10.1 India Next Generation Cancer Diagnostics Market Size (2013-2018)
10.2 Next Generation Cancer Diagnostics Key Players in India
10.3 India Next Generation Cancer Diagnostics Market Size by Type
10.4 India Next Generation Cancer Diagnostics Market Size by Application

11 Central & South America
11.1 Central & South America Next Generation Cancer Diagnostics Market Size (2013-2018)
11.2 Next Generation Cancer Diagnostics Key Players in Central & South America
11.3 Central & South America Next Generation Cancer Diagnostics Market Size by Type
11.4 Central & South America Next Generation Cancer Diagnostics Market Size by Application

12 International Players Profiles
12.1 Cepheid
12.1.1 Cepheid Company Details
12.1.2 Company Description and Business Overview
12.1.3 Next Generation Cancer Diagnostics Introduction
12.1.4 Cepheid Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.1.5 Cepheid Recent Development
12.2 Koninklijke Philips N.V
12.2.1 Koninklijke Philips N.V Company Details
12.2.2 Company Description and Business Overview
12.2.3 Next Generation Cancer Diagnostics Introduction
12.2.4 Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.2.5 Koninklijke Philips N.V Recent Development
12.3 F. Hoffmann-La Roche Ltd
12.3.1 F. Hoffmann-La Roche Ltd Company Details
12.3.2 Company Description and Business Overview
12.3.3 Next Generation Cancer Diagnostics Introduction
12.3.4 F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.3.5 F. Hoffmann-La Roche Ltd Recent Development
12.4 Qiagen
12.4.1 Qiagen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Next Generation Cancer Diagnostics Introduction
12.4.4 Qiagen Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.4.5 Qiagen Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Next Generation Cancer Diagnostics Introduction
12.5.4 Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.5.5 Novartis AG Recent Development
12.6 Abbott
12.6.1 Abbott Company Details
12.6.2 Company Description and Business Overview
12.6.3 Next Generation Cancer Diagnostics Introduction
12.6.4 Abbott Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.6.5 Abbott Recent Development
12.7 Thermo Fisher Scientific
12.7.1 Thermo Fisher Scientific Company Details
12.7.2 Company Description and Business Overview
12.7.3 Next Generation Cancer Diagnostics Introduction
12.7.4 Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.7.5 Thermo Fisher Scientific Recent Development
12.8 Opko Health
12.8.1 Opko Health Company Details
12.8.2 Company Description and Business Overview
12.8.3 Next Generation Cancer Diagnostics Introduction
12.8.4 Opko Health Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.8.5 Opko Health Recent Development
12.9 Myriad Genetics
12.9.1 Myriad Genetics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Next Generation Cancer Diagnostics Introduction
12.9.4 Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.9.5 Myriad Genetics Recent Development
12.10 Agilent Technologies
12.10.1 Agilent Technologies Company Details
12.10.2 Company Description and Business Overview
12.10.3 Next Generation Cancer Diagnostics Introduction
12.10.4 Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2013-2018)
12.10.5 Agilent Technologies Recent Development
12.11 GE Healthcare
12.12 PerkinElmer
12.13 Genomic Health
12.14 Illumina
12.15 Hologic
12.16 Almac Group
12.17 Janssen Global Services
12.18 Sysmex Corporation

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Buy This Premium Report From Here:http://www.amecoresearch.com/buy/5805

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Call: + 1 407 915 4157 | Email: sales@amecoresearch.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here